These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31319019)

  • 61. Trypanocidal activity of new 1,6-diphenyl-1H-pyrazolo[3,4-b]pyridine derivatives: Synthesis, in vitro and in vivo studies.
    Ribeiro JLS; Soares JCAV; Portapilla GB; Providello MV; Lima CHS; Muri EMF; de Albuquerque S; Dias LRS
    Bioorg Med Chem; 2021 Jan; 29():115855. PubMed ID: 33199200
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Structural design, synthesis and pharmacological evaluation of 4-thiazolidinones against Trypanosoma cruzi.
    de Oliveira Filho GB; de Oliveira Cardoso MV; Espíndola JW; Ferreira LF; de Simone CA; Ferreira RS; Coelho PL; Meira CS; Magalhaes Moreira DR; Soares MB; Lima Leite AC
    Bioorg Med Chem; 2015 Dec; 23(23):7478-86. PubMed ID: 26549870
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Assessing anti-T. cruzi candidates in vitro for sterile cidality.
    Cal M; Ioset JR; Fügi MA; Mäser P; Kaiser M
    Int J Parasitol Drugs Drug Resist; 2016 Dec; 6(3):165-170. PubMed ID: 27639944
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Synthesis, biological evaluation and chemometric analysis of indazole derivatives. 1,2-Disubstituted 5-nitroindazolinones, new prototypes of antichagasic drug.
    Vega MC; Rolón M; Montero-Torres A; Fonseca-Berzal C; Escario JA; Gómez-Barrio A; Gálvez J; Marrero-Ponce Y; Arán VJ
    Eur J Med Chem; 2012 Dec; 58():214-27. PubMed ID: 23124218
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Novel nitroimidazole derivatives evaluated for their trypanocidal, cytotoxic, and genotoxic activities.
    do Vale Chaves E Mello F; Castro Salomão Quaresma BM; Resende Pitombeira MC; Araújo de Brito M; Farias PP; Lisboa de Castro S; Salomão K; Silva de Carvalho A; Oliveira de Paula JI; de Brito Nascimento S; Peixoto Cupello M; Paes MC; Boechat N; Felzenszwalb I
    Eur J Med Chem; 2020 Jan; 186():111887. PubMed ID: 31787363
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Activity of "reversed" diamidines against Trypanosoma cruzi "in vitro".
    Silva CF; Batista MM; Mota RA; de Souza EM; Stephens CE; Som P; Boykin DW; Soeiro Mde N
    Biochem Pharmacol; 2007 Jun; 73(12):1939-46. PubMed ID: 17462605
    [TBL] [Abstract][Full Text] [Related]  

  • 67. 6-Methyl-7-Aryl-7-Deazapurine Nucleosides as Anti-Trypanosoma cruzi Agents: Structure-Activity Relationship and in vivo Efficacy.
    Lin C; Ferreira de Almeida Fiuza L; Cardoso Santos C; Ferreira Nunes D; Cruz Moreira O; Bouton J; Karalic I; Maes L; Caljon G; Hulpia F; de Nazaré C Soeiro M; Van Calenbergh S
    ChemMedChem; 2021 Jul; 16(14):2231-2253. PubMed ID: 33856742
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Synthesis and Evaluation of Quinone Derivatives for Activity against Trypanosome cruzi.
    Suto Y; Ascencio T; Nobuta T; Yamagiwa N; Onizuka Y; Ishii M; Kanemitsu K; Nakajima-Shimada J
    Chem Pharm Bull (Tokyo); 2021; 69(12):1195-1199. PubMed ID: 34853286
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In vitro and in vivo studies of the antiparasitic activity of sterol 14α-demethylase (CYP51) inhibitor VNI against drug-resistant strains of Trypanosoma cruzi.
    Soeiro Mde N; de Souza EM; da Silva CF; Batista Dda G; Batista MM; Pavão BP; Araújo JS; Aiub CA; da Silva PB; Lionel J; Britto C; Kim K; Sulikowski G; Hargrove TY; Waterman MR; Lepesheva GI
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4151-63. PubMed ID: 23774435
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Synthesis and biological evaluation of quinones derived from natural product komaroviquinone as anti-Trypanosoma cruzi agents.
    Suto Y; Nakajima-Shimada J; Yamagiwa N; Onizuka Y; Iwasaki G
    Bioorg Med Chem Lett; 2015 Aug; 25(15):2967-71. PubMed ID: 26037321
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The efficacy of novel arylimidamides against Trypanosoma cruzi in vitro.
    DA Silva CF; Daliry A; DA Silva PB; Akay S; Banerjee M; Farahat AA; Fisher MK; Hu L; Kumar A; Liu Z; Stephens CE; Boykin DW; Correia Soeiro MD
    Parasitology; 2011 Dec; 138(14):1863-9. PubMed ID: 21902869
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Trypanosoma cruzi: activities of lapachol and alpha- and beta-lapachone derivatives against epimastigote and trypomastigote forms.
    Salas C; Tapia RA; Ciudad K; Armstrong V; Orellana M; Kemmerling U; Ferreira J; Maya JD; Morello A
    Bioorg Med Chem; 2008 Jan; 16(2):668-74. PubMed ID: 18029184
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Identification of Pyrazolo[3,4-e][1,4]thiazepin based CYP51 inhibitors as potential Chagas disease therapeutic alternative: In vitro and in vivo evaluation, binding mode prediction and SAR exploration.
    Ferreira de Almeida Fiuza L; Peres RB; Simões-Silva MR; da Silva PB; Batista DDGJ; da Silva CF; Nefertiti Silva da Gama A; Krishna Reddy TR; Soeiro MNC
    Eur J Med Chem; 2018 Apr; 149():257-268. PubMed ID: 29501946
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [The chemotherapy of Chagas disease].
    Stoppani AO
    Medicina (B Aires); 1999; 59 Suppl 2():147-65. PubMed ID: 10668258
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Discovery of new potent hits against intracellular Trypanosoma cruzi by QSAR-based virtual screening.
    Melo-Filho CC; Braga RC; Muratov EN; Franco CH; Moraes CB; Freitas-Junior LH; Andrade CH
    Eur J Med Chem; 2019 Feb; 163():649-659. PubMed ID: 30562700
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Synthesis, Biological Evaluation and Molecular Docking of New Benzenesulfonylhydrazone as Potential anti-Trypanosoma cruzi Agents.
    Elizondo-Jimenez S; Moreno-Herrera A; Reyes-Olivares R; Dorantes-Gonzalez E; Nogueda-Torres B; Oliveira EAG; Romeiro NC; Lima LM; Palos I; Rivera G
    Med Chem; 2017; 13(2):149-158. PubMed ID: 27396731
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hydroxamic acid derivatives: a promising scaffold for rational compound optimization in Chagas disease.
    de Menezes Dda R; Calvet CM; Rodrigues GC; de Souza Pereira MC; Almeida IR; de Aguiar AP; Supuran CT; Vermelho AB
    J Enzyme Inhib Med Chem; 2016 Dec; 31(6):964-73. PubMed ID: 26327246
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Synthesis and structure-activity relationship study of a new series of antiparasitic aryloxyl thiosemicarbazones inhibiting Trypanosoma cruzi cruzain.
    Espíndola JW; Cardoso MV; Filho GB; Oliveira E Silva DA; Moreira DR; Bastos TM; Simone CA; Soares MB; Villela FS; Ferreira RS; Castro MC; Pereira VR; Murta SM; Sales Junior PA; Romanha AJ; Leite AC
    Eur J Med Chem; 2015 Aug; 101():818-35. PubMed ID: 26231082
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Synthesis and biological evaluation of new sulfonamide derivatives as potential anti-Trypanosoma cruzi agents.
    Bocanegra-Garcia V; Villalobos-Rocha JC; Nogueda-Torres B; Lemus-Hernandez ME; Camargo-Ordonez A; Rosas-Garcia NM; Rivera G
    Med Chem; 2012 Nov; 8(6):1039-44. PubMed ID: 22762161
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Trypanosoma cruzi: In vitro effect of aspirin with nifurtimox and benznidazole.
    López-Muñoz R; Faúndez M; Klein S; Escanilla S; Torres G; Lee-Liu D; Ferreira J; Kemmerling U; Orellana M; Morello A; Ferreira A; Maya JD
    Exp Parasitol; 2010 Feb; 124(2):167-71. PubMed ID: 19735656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.